US FDA Approves Epidiolex – What it Means

1 min read

Jonathan Havens of Saul Ewing Arnstein & Lehr LLP to talk about what the US FDA’s approval of GW Pharma’s Epidiolex CBD-derived product. 

Havens described what will happen to Epidiolex now – including a possible rescheduling by the US Drug Enforcement Administration.

For more about Epidolex.

For more about Saul Ewing Arnstein & Lehr LLP.

For more about Jonathan Havens.

Previous Story

Quick Hits with Corey Herscu, RNMKR PR

Next Story

Stephanie Karasick, Strainprint Technologies

0 $0.00